lenalidomide
Not Tagged
[' lena', 'lenalidomide', ' aca ', 'lymsm', 'lymphoma', 'dlbcl']
french des-car-t study of pts w post-car-t dlbcl relapse
best responses with bispecific antibodies (orr 37.5%, survival out to a year)
also some promising responses in "targeted therapy" heterogeneous group (see slide)
lenalidomide responses underwhelming
#lymsm #ash22 #tcellrx 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer